Skip to Main Content

Wellcare by Health Net and Trillium Advantage: 2022 Formulary Changes

Date: 11/02/21

On January 1, 2022, some drugs will no longer be covered on our Medicare Part D formulary. To assist our providers, we have included the list below of the most commonly prescribed drugs being removed along with the drug’s 2022 formulary alternative(s). Please refer to the list to identify the appropriate options for your patients. 

 Product Name  Formulary Alternative 
 BYDUREON PEN (product   discontinued)  BYDUREON BCISE AUTO INJ
 AURYXIA CALCIUM ACETATE (PHOS BINDER) CAP/TAB,   SEVELAMER CARBONATE
 TRULANCE LINZESS CAP, LUBIPROSTONE CAP
 BRINZOLAMIDE OPHTH SUSP   1% AZOPT, DORZOLAMIDE

If you determine that it is necessary for your patient to continue to receive the non-formulary drug in 2022, you will need to submit a Coverage Determination request on or after November 1, 2021.

Request forms are located on our website at WellCare by Health Net and WellCare by Trillium Advantage on the Coverage Determinations and Redeterminations for Drugs page or you can call to request authorization.

If you have any questions, please contact Medicare Pharmacy Services at 1-855-538-0454.